Literature DB >> 24570045

Generation of adenosine tri-phosphate in Leishmania donovani amastigote forms.

Subhasish Mondal1, Jay Jyoti Roy, Tanmoy Bera.   

Abstract

Leishmania, the causative agent of various forms of leishmaniasis, is the significant cause of morbidity and mortality. Regarding energy metabolism, which is an essential factor for the survival, parasites adapt to the environment under low oxygen tension in the host using metabolic systems which are very different from that of the host mammals. We carried out the study of susceptibilities to different inhibitors of mitochondrial electron transport chain and studies on substrate level phosphorylation in wild-type L. donovani. The amastigote forms of L. donovani are independent on oxidative phosphorylation for ATP production. Indeed, its cell growth was not inhibited by excess oligomycin and dicyclohexylcarbodiimide, which are the most specific inhibitors of the mitochondrial Fo/F1-ATP synthase. In contrast, mitochondrial complex I inhibitor rotenone and complex III inhibitor antimycin A inhibited amastigote cell growth, suggesting the role of complex I and complex III in cell survival. Complex II appeared to have no role in cell survival. To further investigate the site of ATP production, we studied the substrate level phosphorylation, which was involved in the synthesis of ATP. Succinate-pyruvate couple showed the highest substrate level phosphorylation in amastigotes whereas NADH-fumarate and NADH-pyruvate couples failed to produce ATP. In contrast, NADPH-fumarate showed the highest rate of ATP formation in promastigotes. Therefore, we can conclude that substrate level phosphorylation is essential for the survival of amastigote forms of Leishmania donovani.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24570045     DOI: 10.2478/s11686-014-0203-9

Source DB:  PubMed          Journal:  Acta Parasitol        ISSN: 1230-2821            Impact factor:   1.440


  4 in total

Review 1.  Dependence of Leishmania parasite on host derived ATP: an overview of extracellular nucleotide metabolism in parasite.

Authors:  Kashika Arora; Ambak Kumar Rai
Journal:  J Parasit Dis       Date:  2018-12-01

2.  Discovery of Novel Pyruvate Kinase Inhibitors Against Leishmania major Among FDA Approved Drugs Through System Biology and Molecular Docking Approach.

Authors:  Nasrin Amiri-Dashatan; Mostafa Rezaei-Tavirani; Mohammad Mehdi Ranjbar; Mehdi Koushki; Seyed Dawood Mousavi Nasab; Nayebali Ahmadi
Journal:  Turk J Pharm Sci       Date:  2021-12-31

3.  Characterization of mitochondrial bioenergetic functions between two forms of Leishmania donovani - a comparative analysis.

Authors:  Subhasish Mondal; Jay Jyoti Roy; Tanmoy Bera
Journal:  J Bioenerg Biomembr       Date:  2014-08-10       Impact factor: 2.945

4.  Universal minicircle sequence binding protein of Leishmania donovani regulates pathogenicity by controlling expression of cytochrome-b.

Authors:  Ruby Singh; Bidyut Purkait; Kumar Abhishek; Savita Saini; Sushmita Das; Sudha Verma; Abhishek Mandal; Ayan Kr Ghosh; Yousuf Ansari; Ashish Kumar; Abul H Sardar; Ajay Kumar; Pradeep Parrack; Pradeep Das
Journal:  Cell Biosci       Date:  2016-02-17       Impact factor: 9.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.